We are live on ! Find out more
SOCM

SR One Capital Management Portfolio holdings

AUM $915M
1-Year Est. Return 209.71%
This Fund
S&P 500
This Quarter Est. Return
-19.25%
1 Year Est. Return
+209.71%
3 Year Est. Return
+484.66%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$319M
AUM Growth
-$44.7M
Cap. Flow
+$35.4M
Cap. Flow %
11.09%
Top 10 Hldgs %
100%
Holding
9
New
3
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ALMS
Alumis Inc
ALMS
+$26.1M
2
ENGN icon
enGene Therapeutics
ENGN
+$6.41M
3
KALA icon
KALA BIO
KALA
+$2.93M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACLX
1
DELISTED
Arcellx
ACLX
$130M 40.55%
2,346,630
– –
CRSP icon
2
CRISPR Therapeutics
CRSP
$5.23B
$56.7M 17.74%
1,048,951
– –
SPRY icon
3
ARS Pharmaceuticals
SPRY
$591M
$34.1M 10.69%
4,012,903
– –
ALMS
4
Alumis Inc
ALMS
$3.23B
$26.1M 8.16%
+1,959,896
New +$26.1M
MLYS icon
5
Mineralys Therapeutics
MLYS
$2.41B
$23.6M 7.39%
2,016,822
– –
DSGN icon
6
Design Therapeutics
DSGN
$915M
$21.9M 6.85%
6,526,476
– –
NKTX icon
7
Nkarta
NKTX
$167M
$19.7M 6.17%
3,333,333
– –
ENGN icon
8
enGene Therapeutics
ENGN
$122M
$4.71M 1.48%
+500,000
New +$6.41M
KALA icon
9
KALA BIO
KALA
$16.3M
$3.15M 0.98%
+8,873
New +$2.93M

Similar funds

PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
SC
Sierra Capital Miami, Florida $918M AUM 8.25% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
FFL
Flat Footed LLC Wilson, Wyoming $920M AUM 86.47% 1-Year Est. Return

SR One Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, SR One Capital Management held 9 positions worth $319M, down 12% from $364M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SR One Capital Management deployed $35.4M of net new capital in Q2 2024, opening 3 new positions. Its largest new stake was Alumis Inc: 1,959,896 shares worth $26.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • SR One Capital Management's largest Q2 2024 buy was Alumis Inc: 1,959,896 shares worth $26.1M.
  • SR One Capital Management's ten largest holdings make up 100% of its $319M portfolio in Q2 2024.
  • SR One Capital Management opened 3 new positions and closed 0 in Q2 2024.
  • SR One Capital Management's portfolio value fell 12% quarter-over-quarter to $319M.

Based on SR One Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.